Andere Sprachen Opyl Limited Australian S.E.

Aktien

Schlusskurs Australian S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^AUD	-.--%		-.--%	-.--%

20.03.	Opyl beantragt Handelsstopp nach Erhalt des Angebots für Opin Business	MT
15.03.	Opyl Vorsitzender tritt Ende April zurück	MT

Opyl Secures First TrialGen Contract with Brain Vector	06.06.
Opyl Expands TrialKey Coverage; Shares Up 38%	29.04.
Opyl to Divest Opin Business	23.04.
Opyl Receives Offer for Patient Recruitment Business	22.03.
Trial Screen Pty Ltd entered into a non-binding offer to acquire Opin business from Opyl Limited.	22.03.
Opyl Requests Trading Halt After Receiving Offer For Opin Business	20.03.
Opyl Chair Stepping Down in End-April	15.03.
Opyl Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28.02.
Opyl Raises Nearly AU$900,000 from Rights Issue Shortfall Placement	09.02.
Opyl Grows Cash Receipts for Fiscal Q2	31.01.
Opyl Receives Commitments for Potential Shortfall	02.01.
Opyl Appoints Interim CEO	24.11.
Opyl Limited Appoints Saurabh Jain as Interim Chief Executive Officer	23.11.
Opyl Secures R&D Tax Rebate for Fiscal Year 2023	22.09.23
Opyl Limited Announces Appointment of Antanas Guoga as Director, Effective from September 4, 2023	05.09.23
Opyl Limited Announces Board Update	04.09.23
Opyl Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30.08.23
Opyl Limited Launches TrialKey MVP	24.08.23
Opyl Limited Announces Senior Leadership Changes	05.07.23
Opyl Limited Announces Resignation of Michelle Gallaher as CEO	05.07.23

Keine Ergebnisse zu dieser Suche